<?xml version="1.0" encoding="UTF-8"?>
<p>The novel recombinant VLP vaccine platforms included VLPs prepared in mammalian, insect, and plant expression systems. Recombinant VLPs are morphologically and biochemically similar to the wild type influenza virus (
 <xref ref-type="fig" rid="viruses-12-00518-f002">Figure 2</xref>); however, they lack viral genetic material and are unable to replicate and cause infection. 
 <xref rid="viruses-12-00518-t002" ref-type="table">Table 2</xref> shows examples of various VLPs prepared from H7N9 virus antigens. Cell culture-based production of VLPs can potentially overcome limitations of classic influenza vaccines [
 <xref rid="B36-viruses-12-00518" ref-type="bibr">36</xref>].
</p>
